In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.

Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer’s disease, the researchers observed how the loss of ADGRG1 led to the rapid buildup of ...

The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...

The newest rage in Hindi cinema, Saiyaara, is breaking records at the movie theatres, depicting a love story of a girl in her ...

Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.